Lower nucleus accumbens volume independently predicts depressive symptoms and future anhedonia in patients with early relapsing-remitting MS.

For the first time, physicists have developed a model that explains the origins of unusually stable magic nuclei based ...

Red Nucleus is doubling down on health economics and outcomes research (HEOR) as payer scrutiny, pricing pressure and evidence demands reshape how therapies reach — and stay on — the market.

Researchers at the University of Jyväskylä (Finland), in cooperation with national and international research groups, have ...

Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus. The ...

Nucleus Genomics, a genetic testing company focused on calculating a patient’s risk of certain diseases, is adding $14 million to their initial seed funding round. With this round the company has ...